BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24174342)

  • 1. Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model.
    de Visscher SA; Witjes MJ; van der Vegt B; de Bruijn HS; van der Ploeg-van den Heuvel A; Amelink A; Sterenborg HJ; Roodenburg JL; Robinson DJ
    Lasers Surg Med; 2013 Dec; 45(10):668-78. PubMed ID: 24174342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window-chamber tumor model.
    de Visscher SA; Kaščáková S; de Bruijn HS; van den Heuvel Av; Amelink A; Sterenborg HJ; Robinson DJ; Roodenburg JL; Witjes MJ
    Lasers Surg Med; 2011 Aug; 43(6):528-36. PubMed ID: 21761424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photochemical internalization (PCI)-mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells.
    Peng W; Samplonius DF; de Visscher S; Roodenburg JL; Helfrich W; Witjes MJ
    Lasers Surg Med; 2014 Oct; 46(8):650-8. PubMed ID: 25174329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.
    Meier D; Botter SM; Campanile C; Robl B; Gräfe S; Pellegrini G; Born W; Fuchs B
    Int J Cancer; 2017 Apr; 140(7):1680-1692. PubMed ID: 27943293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines.
    Kiesslich T; Berlanda J; Plaetzer K; Krammer B; Berr F
    Photochem Photobiol Sci; 2007 Jun; 6(6):619-27. PubMed ID: 17549263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative characterization of the cellular uptake and photodynamic efficiency of Foscan® and Fospeg in a human prostate cancer cell line.
    Petri A; Yova D; Alexandratou E; Kyriazi M; Rallis M
    Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):344-54. PubMed ID: 23200016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and biodistribution study following systemic administration of Fospeg®--a Pegylated liposomal mTHPC formulation in a murine model.
    Xie H; Svenmarker P; Axelsson J; Gräfe S; Kyriazi M; Bendsoe N; Andersson-Engels S; Svanberg K
    J Biophotonics; 2015 Jan; 8(1-2):142-52. PubMed ID: 24375973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and photo-toxicity of Foscan®, Foslip® and Fospeg® in multicellular tumor spheroids.
    Gaio E; Scheglmann D; Reddi E; Moret F
    J Photochem Photobiol B; 2016 Aug; 161():244-52. PubMed ID: 27285816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
    Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G
    J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC.
    Lassalle HP; Dumas D; Gräfe S; D'Hallewin MA; Guillemin F; Bezdetnaya L
    J Control Release; 2009 Mar; 134(2):118-24. PubMed ID: 19100297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.
    Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H
    Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution characteristics in vivo.
    Reshetov V; Lassalle HP; François A; Dumas D; Hupont S; Gräfe S; Filipe V; Jiskoot W; Guillemin F; Zorin V; Bezdetnaya L
    Int J Nanomedicine; 2013; 8():3817-31. PubMed ID: 24143087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of tetra(m-hydroxyphenyl)chlorin (Foscan) in human healthy tissues and squamous cell carcinomas of the upper aero-digestive tract, the esophagus and the bronchi: a fluorescence microscopy study.
    Andrejevic Blant S; Grosjean P; Ballini JP; Wagnières G; van den Bergh H; Fontolliet C; Monnier P
    J Photochem Photobiol B; 2001 Aug; 61(1-2):1-9. PubMed ID: 11485842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy.
    Bovis MJ; Woodhams JH; Loizidou M; Scheglmann D; Bown SG; Macrobert AJ
    J Control Release; 2012 Jan; 157(2):196-205. PubMed ID: 21982898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and localisation of mTHPC (Foscan) and its 14C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study.
    Blant SA; Glanzmann TM; Ballini JP; Wagnières G; van den Bergh H; Monnier P
    Br J Cancer; 2002 Dec; 87(12):1470-8. PubMed ID: 12454779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy with intratumoral administration of Lipid-Based mTHPC in a model of breast cancer recurrence.
    D'Hallewin MA; Kochetkov D; Viry-Babel Y; Leroux A; Werkmeister E; Dumas D; Gräfe S; Zorin V; Guillemin F; Bezdetnaya L
    Lasers Surg Med; 2008 Oct; 40(8):543-9. PubMed ID: 18798287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial dysplasia and squamous cell carcinoma of the Wistar rat palatal mucosa: 4NQO model.
    Nauta JM; Roodenburg JL; Nikkels PG; Witjes MJ; Vermey A
    Head Neck; 1996; 18(5):441-9. PubMed ID: 8864735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
    Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
    Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy for cholangiocarcinoma using low dose mTHPC (Foscan(®)).
    Kniebühler G; Pongratz T; Betz CS; Göke B; Sroka R; Stepp H; Schirra J
    Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):220-8. PubMed ID: 23993847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo quantification of photosensitizer concentration using fluorescence differential path-length spectroscopy: influence of photosensitizer formulation and tissue location.
    de Visscher SA; Witjes MJ; Kascáková S; Sterenborg HJ; Robinson DJ; Roodenburg JL; Amelink A
    J Biomed Opt; 2012 Jun; 17(6):067001. PubMed ID: 22734779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.